Page 1 of Clinical Trials for Abatacept, 97 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After SC Administration to Subjects With RA
Last Updated: April 30, 2012
Condition(s): Rheumatoid Arthritis
2
Completed
Pharmacokinetic Study to Compare the Blood Levels of Abatacept Manufactured at Lonza Biologics to the Blood Levels of Abatacept Manufactured at the Devens, MA Facility of Bristol-Myers Squibb
Last Updated: April 30, 2012
Condition(s): Rheumatoid Arthritis
3
Completed
Vaccination Study of Abatacept (BMS-188667) for Normal Healthy Volunteers
Last Updated: April 11, 2011
Condition(s): Rheumatoid Arthritis
4
Completed
Phase IIIB Subcutaneous Abatacept Monotherapy Study
Last Updated: February 7, 2012
Condition(s): Rheumatoid Arthritis (RA)
5
Completed
Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy
Last Updated: February 23, 2012
Condition(s): Rheumatoid Arthritis
6
Active, not recruiting
Efficacy, Pharmacokinetics, Safety and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japan
Last Updated: February 15, 2012
Condition(s): Rheumatoid Arthritis
7
Completed
A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
Last Updated: October 26, 2011
Condition(s): Rheumatoid Arthritis
8
Completed
A Study of Abatacept in Patients With Active Ulcerative Colitis
Last Updated: November 4, 2010
Condition(s): Ulcerative Colitis
9
Completed
Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis
Last Updated: December 21, 2010
Condition(s): Rheumatoid Arthritis
10
Completed
Methotrexate-Inadequate Response Study
Last Updated: February 28, 2012
Condition(s): Rheumatoid Arthritis (RA)
11
Terminated
A Study of Abatacept in Patients With Active Crohn's Disease
Last Updated: September 10, 2010
Condition(s): Crohn's Disease
12
Completed
Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone
Last Updated: May 26, 2011
Condition(s): Systemic Lupus Erythematosus
13
Active, not recruiting
Real-world Clinical Efficacy of Abatacept in the T3 Data Registry
Last Updated: March 16, 2012
Condition(s): Arthritis, Rheumatoid
14
Completed
Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past.
Last Updated: November 14, 2011
Condition(s): Rheumatoid Arthritis
15
Completed
A Phase III Study of Abatacept in Patients With Rheumatoid Arthritis, With an Inadequate Response to Methotrexate
Last Updated: February 2, 2012
Condition(s): Rheumatoid Arthritis
16
Recruiting
Safety and Tolerability Trial of Abatacept-based Immunosuppression for Prevention of Acute Graft Versus Host Disease (aGVHD) During Transplant
Last Updated: November 12, 2009
Condition(s): AML; ALL; Undifferentiated Leukemia; Biphenotypic Leukemia; Refractory Anemia; Refractory Anemia With Ringed Sideroblasts; Refractory Cytopenia With Multilineage Dysplasia; Refractory Cytopenia With Multilineage Dysplasia and Ringed Sideroblasts; Refractory Anemia With Excess Blasts-1 (5-10% Blasts); Refractory Anemia With Excess Blasts-2 (10-20% Blasts); Myelodysplastic Syndrome, Unclassified; MDS Associated With Isolated Del (5q)
17
Not yet recruiting
TOward the Lowest Effective DOse of Abatacept or Tocilizumab
Last Updated: March 16, 2012
Condition(s): Rheumatoid Arthritis
18
Active, not recruiting
Phase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kg
Last Updated: February 17, 2012
Condition(s): Lupus Nephritis
19
Terminated
Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis
Last Updated: April 12, 2012
Condition(s): Psoriatic Arthritis
20
Completed
A Study to Assess the Receptor Occupancy of CD86 and CD80 in Subjects With Rheumatoid Arthritis Initiating Abatacept
Last Updated: November 28, 2011
Condition(s): Rheumatoid Arthritis

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Abatacept

Page 1 of Clinical Trials for Abatacept, 97 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About